ResearcherLevanger HospitalActive in the last 2 years
Sara Fanijavadi
Matched on ORCID iD 0000-0001-9977-5479; OpenAlex author ID A5115508195. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 1
2025: 2 papers · 2026: 1 paper
Papers 3
- Targeting Reactive Species Stress and Nutrient Sensing to Enhance NK-Cell Function: Mechanistic Strategies for Overcoming Pancreatic Cancer Progression and Res… Co-author DOI 10.3390/ijms27177893↗
- Targeting Triple NK Cell Suppression Mechanisms: A Comprehensive Review of Biomarkers in Pancreatic Cancer Therapy. Co-author DOI 10.3390/ijms26020515↗
- Dysbiosis-NK Cell Crosstalk in Pancreatic Cancer: Toward a Unified Biomarker Signature for Improved Clinical Outcomes. Co-author DOI 10.3390/ijms26020730↗
Closest collaborators
The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Lars Henrik Jensen · 3 shared papers, 2025–2026 · strength 1.59
- Paper Targeting Reactive Species Stress and Nutrient Sensing to Enhance NK-Cell Function: Mechanistic Strategies for Overcomi… DOI 10.3390/ijms27177893↗
- Paper Dysbiosis-NK Cell Crosstalk in Pancreatic Cancer: Toward a Unified Biomarker Signature for Improved Clinical Outcomes. DOI 10.3390/ijms26020730↗
- Paper Targeting Triple NK Cell Suppression Mechanisms: A Comprehensive Review of Biomarkers in Pancreatic Cancer Therapy. DOI 10.3390/ijms26020515↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.